organization · Reporting owner

RED Holdings, LLC

Disclosed activity across 1 company

Tapewire entity: 84207
SEC CIK: 0001900525

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Organogenesis Holdings Inc.ORGO · Entity 6275	10% owner	January 09, 2025	January 13, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Organogenesis Holdings Inc.

Report date January 09, 2025 · Filed January 13, 2025

Jointly reported with Ades Alan A., Ades Josette, GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016, Erani Dennis, Wisdom Starr

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	51,085,402	Reported balance After 2025-01-09 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2025-01-09 · Gift · Disposed 6,401,945 · Balance 51,085,402 F1: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group.
Class A Common StockSEC Table I · non-derivative	Direct	51,085,402	Reported balance After 2025-01-09 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2025-01-09 · Gift · Acquired 6,401,945 · Balance 51,085,402 F1: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group.
Class A Common StockSEC Table I · non-derivative	IndirectBy spouse	51,085,402	Reported balance After 2025-01-09 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2025-01-09 · Gift · Acquired 6,401,945 · Balance 51,085,402 F1: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group.

Filing footnotes · ownership attribution and instrument terms

F1: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities.

F2: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
January 09, 2025 Filed Jan 13, 2025 17:03 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GiftClass A Common Stock	6,401,945	$0.00	$0.00	Disclosure SEC source: 0001062993-25-000728 · form4.xml · nonDerivative · entry 3 Ades Alan A. · CIK 0001757286 · Director · 10% owner Ades Josette · CIK 0002050939 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,085,402 F1 · kind: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document
January 09, 2025 Filed Jan 13, 2025 17:03 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GiftClass A Common Stock	6,401,945	$0.00	$0.00	Disclosure SEC source: 0001062993-25-000728 · form4.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner Ades Josette · CIK 0002050939 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 51,085,402 F1 · kind: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document
January 09, 2025 Filed Jan 13, 2025 17:03 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GiftClass A Common Stock	6,401,945	$0.00	$0.00	Disclosure SEC source: 0001062993-25-000728 · form4.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner Ades Josette · CIK 0002050939 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,085,402 F1 · kind: On January 9, 2025, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document
December 31, 2024 Filed Jan 3, 2025 19:22 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GiftClass A Common Stock	1,710,552	$0.00	$0.00	Disclosure SEC source: 0001062993-25-000287 · form4.xml · nonDerivative · entry 3 Ades Alan A. · CIK 0001757286 · Director · 10% owner Ades Josette · CIK 0002050939 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,085,403 F1 · kind: On December 31, 2024, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document
December 31, 2024 Filed Jan 3, 2025 19:22 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GiftClass A Common Stock	1,710,552	$0.00	$0.00	Disclosure SEC source: 0001062993-25-000287 · form4.xml · nonDerivative · entry 2 Ades Alan A. · CIK 0001757286 · Director · 10% owner Ades Josette · CIK 0002050939 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By spouse Disclosed balance after: 51,085,403 F1 · kind: On December 31, 2024, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document
December 31, 2024 Filed Jan 3, 2025 19:22 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GiftClass A Common Stock	1,710,552	$0.00	$0.00	Disclosure SEC source: 0001062993-25-000287 · form4.xml · nonDerivative · entry 1 Ades Alan A. · CIK 0001757286 · Director · 10% owner Ades Josette · CIK 0002050939 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,085,403 F1 · kind: On December 31, 2024, the reported securities, which were directly held by Alan A. Ades, a member of the Group (as defined below), were transferred to his spouse, Josette Ades, who is a member of the Group, as a gift for no consideration for estate planning purposes. Alan A. Ades disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that Alan A. Ades is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document
November 27, 2024 Filed Dec 2, 2024 16:48 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	Disposition to issuerClass A Common Stock	500,000	$4.06	$2,028,500.00	Disclosure SEC source: 0001062993-24-019880 · form4.xml · nonDerivative · entry 1 GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner ERANI ALBERT · CIK 0001074084 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,085,403 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 26, 2024. F2 · balance_after: Reflects the total number of securities held by the Group. Only the GN 2016 Family Trust u/a/d August 12, 2016 has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected in the first line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares, except for Glenn H. Nussdorf, who disclaims ownership of the shares held by the GN 2016 Family Trust u/a/d August 12, 2016, except to the extent of his pecuniary interest therein. Read SEC document
November 12, 2024 Filed Nov 14, 2024 19:27 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	Disposition to issuerClass A Common Stock	2,550,822	$3.16	$8,059,832.27	Disclosure SEC source: 0001062993-24-019189 · form4.xml · nonDerivative · entry 5 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,585,403 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F6 · balance_after: Reflects the total number of securities held by the Group. Only Glenn H. Nussdorf has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected on the fifth line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares. Read SEC document
November 12, 2024 Filed Nov 14, 2024 19:27 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	Disposition to issuerClass A Common Stock	3,761,909	$3.16	$11,886,503.87	Disclosure SEC source: 0001062993-24-019189 · form4.xml · nonDerivative · entry 4 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,136,225 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F5 · balance_after: Reflects the total number of securities held by the Group. Only the Alan Ades 2014 GRAT has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected in the fourth line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares, except for Alan A. Ades, who is the Trustee of the Alan Ades 2014 GRAT, and who disclaims ownership of the shares held by the Alan Ades 2014 GRAT, except to the extent of his pecuniary interest therein. Read SEC document
November 12, 2024 Filed Nov 14, 2024 19:27 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	Disposition to issuerClass A Common Stock	294,000	$3.16	$928,951.80	Disclosure SEC source: 0001062993-24-019189 · form4.xml · nonDerivative · entry 3 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,898,134 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F4 · balance_after: Reflects the total number of securities held by the Group. Only Alan A. Ades has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected on the third line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares. Read SEC document
November 12, 2024 Filed Nov 14, 2024 19:27 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	OtherClass A Common Stock	590,332	$3.16	$1,865,272.02	Disclosure SEC source: 0001062993-24-019189 · form4.xml · nonDerivative · entry 2 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,192,134 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F3 · balance_after: Reflects the total number of securities held by the Group. Only RED Holdings, LLC has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected in the second line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein. Read SEC document
November 12, 2024 Filed Nov 14, 2024 19:27 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	OtherClass A Common Stock	224,668	$3.16	$709,883.48	Disclosure SEC source: 0001062993-24-019189 · form4.xml · nonDerivative · entry 1 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Wisdom Starr · CIK 0001760694 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,782,466 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F2 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected on the first line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares. Read SEC document
November 12, 2024 Filed Nov 14, 2024 19:27 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	Disposition to issuerClass A Common Stock	2,550,822	$3.16	$8,059,832.27	Disclosure SEC source: 0001062993-24-019188 · form4.xml · nonDerivative · entry 5 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,585,403 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F6 · balance_after: Reflects the total number of securities held by the Group. Only Glenn H. Nussdorf has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected on the fifth line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares. Read SEC document
November 12, 2024 Filed Nov 14, 2024 19:27 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	Disposition to issuerClass A Common Stock	3,761,909	$3.16	$11,886,503.87	Disclosure SEC source: 0001062993-24-019188 · form4.xml · nonDerivative · entry 4 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,136,225 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F5 · balance_after: Reflects the total number of securities held by the Group. Only the Alan Ades 2014 GRAT has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected in the fourth line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares, except for Alan A. Ades, who is the Trustee of the Alan Ades 2014 GRAT, and who disclaims ownership of the shares held by the Alan Ades 2014 GRAT, except to the extent of his pecuniary interest therein. Read SEC document
November 12, 2024 Filed Nov 14, 2024 19:27 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	Disposition to issuerClass A Common Stock	294,000	$3.16	$928,951.80	Disclosure SEC source: 0001062993-24-019188 · form4.xml · nonDerivative · entry 3 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,898,134 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F4 · balance_after: Reflects the total number of securities held by the Group. Only Alan A. Ades has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected on the third line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares. Read SEC document
November 12, 2024 Filed Nov 14, 2024 19:27 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	OtherClass A Common Stock	590,332	$3.16	$1,865,272.02	Disclosure SEC source: 0001062993-24-019188 · form4.xml · nonDerivative · entry 2 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,192,134 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F3 · balance_after: Reflects the total number of securities held by the Group. Only RED Holdings, LLC has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected in the second line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein. Read SEC document
November 12, 2024 Filed Nov 14, 2024 19:27 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	OtherClass A Common Stock	224,668	$3.16	$709,883.48	Disclosure SEC source: 0001062993-24-019188 · form4.xml · nonDerivative · entry 1 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner Ades Alan A. · CIK 0001757286 · Director · 10% owner Alan Ades 2014 GRAT · CIK 0001757567 · 10% owner NUSSDORF GLENN H · CIK 0001244191 · Director · 10% owner Dennis Erani 2012 Issue Trust dated 12/20/12 · CIK 0001757455 · 10% owner Organo PFG LLC · CIK 0001757580 · 10% owner Organo Investors LLC · CIK 0001757573 · 10% owner GN 2016 Family Trust u/a/d August 12, 2016 · CIK 0001757453 · 10% owner Albert Erani Family Trust dated 12/29/2012 · CIK 0001760663 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,782,466 F1 · price: The price reported in Column 4 is the 10-day trailing volume weighted average price of the Class A common stock as of market close on November 11, 2024. F2 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares redeemed by Organogenesis pursuant to a Stock Repurchase Agreement reflected on the first line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in such shares. Read SEC document
January 10, 2024 Filed Jan 11, 2024 16:44 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	SaleClass A Common Stock	17,972	$4.28	$76,875.23	Disclosure SEC source: 0001062993-24-000799 · form4.xml · nonDerivative · entry 2 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,007,134 F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $4.20 to $4.34, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. F4 · balance_after: Reflects the total number of securities held by the Group. Only RED Holdings, LLC has a pecuniary interest in the shares being sold pursuant to the second line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to the second line of Table I of this Form 4, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein. Read SEC document
January 09, 2024 Filed Jan 11, 2024 16:44 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	SaleClass A Common Stock	197,921	$4.37	$863,984.54	Disclosure SEC source: 0001062993-24-000799 · form4.xml · nonDerivative · entry 1 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,025,106 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $4.30 to $4.45, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to the first line of Table I of this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to the first line of Table I of this Form 4. Read SEC document
April 12, 2023 Filed Apr 14, 2023 18:28 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	SaleClass A Common Stock	25,000	$2.07	$51,772.50	Disclosure SEC source: 0001062993-23-009196 · form4.xml · nonDerivative · entry 1 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,223,027 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $2.0701 to $2.0801, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4. Read SEC document
June 13, 2022 Filed Jun 13, 2022 17:44 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	SaleClass A Common Stock	29,669	$4.89	$145,081.41	Disclosure SEC source: 0001062993-22-014816 · form4.xml · nonDerivative · entry 2 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,248,027 F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $4.83 to $4.95, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4. Read SEC document
June 09, 2022 Filed Jun 13, 2022 17:44 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	SaleClass A Common Stock	331	$5.30	$1,754.30	Disclosure SEC source: 0001062993-22-014816 · form4.xml · nonDerivative · entry 1 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,277,696 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.31, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F3 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4. Read SEC document
June 08, 2022 Filed Jun 8, 2022 19:13 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	SaleClass A Common Stock	20,000	$5.39	$107,800.00	Disclosure SEC source: 0001062993-22-014508 · form4.xml · nonDerivative · entry 3 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,278,027 F3 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.34 to $5.49, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4. F4 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4. Read SEC document
June 07, 2022 Filed Jun 8, 2022 19:13 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	SaleClass A Common Stock	50,000	$5.49	$274,500.00	Disclosure SEC source: 0001062993-22-014508 · form4.xml · nonDerivative · entry 2 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,298,027 F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.33 to $5.54, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F4 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4. Read SEC document
June 06, 2022 Filed Jun 8, 2022 19:13 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	SaleClass A Common Stock	100,000	$5.41	$541,000.00	Disclosure SEC source: 0001062993-22-014508 · form4.xml · nonDerivative · entry 1 ERANI ALBERT · CIK 0001074084 · 10% owner RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,348,027 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.55, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F4 · balance_after: Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4. Read SEC document
December 28, 2021 Filed Dec 30, 2021 21:31 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GiftClass A Common Stock	7,392,328	$0.00	$0.00	Disclosure SEC source: 0001062993-21-013662 · form4.xml · nonDerivative · entry 4 RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F3 · shares: On December 28, 2021, the reported securities, which were directly held by the Albert Erani Family Trust dated 12/29/2012, a member of the Group, were transferred to RED Holdings, LLC, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document
December 28, 2021 Filed Dec 30, 2021 21:31 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GiftClass A Common Stock	7,392,328	$0.00	$0.00	Disclosure SEC source: 0001062993-21-013662 · form4.xml · nonDerivative · entry 3 RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F3 · shares: On December 28, 2021, the reported securities, which were directly held by the Albert Erani Family Trust dated 12/29/2012, a member of the Group, were transferred to RED Holdings, LLC, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities, except for Albert Erani, who is the sole manager of RED Holdings, LLC, and who disclaims ownership of the shares held by RED Holdings, LLC, except to the extent of his pecuniary interest therein. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document
December 28, 2021 Filed Dec 30, 2021 21:31 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GiftClass A Common Stock	4,661,129	$0.00	$0.00	Disclosure SEC source: 0001062993-21-013662 · form4.xml · nonDerivative · entry 2 RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,448,027 F1 · shares: On December 28, 2021, the reported securities, which were indirectly held by Albert Erani, a member of the Group (as defined below), were transferred by the Albert Erani 2014 GRAT to the Albert Erani Family Trust dated 12/29/2012, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document
December 28, 2021 Filed Dec 30, 2021 21:31 UTC	Organogenesis Holdings Inc. ORGO · Entity 6275	GiftClass A Common Stock	4,661,129	$0.00	$0.00	Disclosure SEC source: 0001062993-21-013662 · form4.xml · nonDerivative · entry 1 RED Holdings, LLC · CIK 0001900525 · 10% owner GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 · CIK 0001757452 · 10% owner Erani Dennis · CIK 0001760685 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By the Albert Erani 2014 GRAT Disclosed balance after: 59,448,027 F1 · shares: On December 28, 2021, the reported securities, which were indirectly held by Albert Erani, a member of the Group (as defined below), were transferred by the Albert Erani 2014 GRAT to the Albert Erani Family Trust dated 12/29/2012, which is a member of the Group, as a gift for no consideration for estate planning purposes. None of the other members of the Group has a pecuniary interest in the transferred securities. F2 · balance_after: Reflects the total number of securities held by the Group. There was no change to the total number of securities because, at all times, the transferred shares were held, either directly or indirectly, by a member of the Group. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.